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Abstract The goal of the study was to establish whether contraction (retraction) of thrombi and/or thrombotic emboli occurs
in vivo using morphological signs of blood clot compression, such as characteristic deformation of erythrocytes and redistribu-
tion of fibrin toward the surface of a thrombus/embolus. Three postmortem human pulmonary thrombotic emboli were examined
by scanning electron microscopy and light microscopy after staining with hematoxylin and eosin as well as with Mallory’s stain.
In two pulmonary emboli, which were extracted at 7 and 15 h after death of the patients, compressed polyhedral erythrocytes
(polyhedrocytes) were revealed that were formed due to mechanical deformation under the action of contractile forces generated
by activated platelets. In addition, the uneven distribution of fibrin within the emboli was found with accumulation of fibrin at the
periphery of the emboli, which is another structural characteristic of a contracted blood clot. In one of the three emboli analyzed,
which was extracted 38 h after the patient’s death (the Boldest^ embolus), the morphological signs of contraction were absent,
which was likely related to the partial postmortem autolysis of the embolus or intravital impairment of contraction. The ex vivo
thrombotic emboli have morphological signs of clot contraction, suggesting intravital compression of the primary thrombi and/or
thrombotic emboli. The in vivo contraction of thrombi and emboli may be an important pathogenic mechanism for modulation of
blood flow past otherwise obstructive clots at the sites of thrombotic occlusion of a vessel. The presence of compressed
erythrocytes inside and the predominant location of fibrin around the periphery of a thrombus or embolus can potentially serve
as additional pathomorphological criteria for the intravital contraction of thrombi and thrombotic emboli.
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1 Introduction
Venous thromboembolism, which includes deep vein thrombo-
sis, either isolated or associated with pulmonary embolism, is
the third most common cardiovascular disorder and a major
cause of morbidity and mortality worldwide [1]. Venous throm-
boembolism causes from 60,000 to 300,000 deaths each year
among approximately 900,000 new cases in the USA [2].
Thrombotic emboli are the most frequent type of embolism that
develop due to detachment of an entire thrombus or separation
of its part. The size of thrombotic emboli can vary up to several
centimeters. Venous thromboembolism complicates cancer,
infections, cardiovascular diseases, andmany other pathological
states [3, 4]. Despite tremendous clinical importance, the mech-
anisms of thrombotic embolism remain largely unclear and the
results of prophylaxis and treatment remain unsatisfactory.
In the vast majority of cases, the primary thrombotic occlu-
sion occurs in the veins of the systemic circuit or in the right
heart chambers, where fragments of the thrombus are carried
by the blood flow into the pulmonary artery, leading to pulmo-
nary embolism [4, 5]. Pulmonary embolism causes right ven-
tricular failure and/or pulmonary infarction (when small and
medium branches of the pulmonary artery are blocked) or
sudden death (when the embolus is located in the trunk and
in the large branches of the pulmonary artery). In the latter
case, the mechanism of death includes a cardiopulmonary re-
flex accompanied by the coronary spasm. Thus, venous throm-
boembolism is a potentially lethal complication of thrombosis
[4]; therefore, its prevention needs thromboprophylaxis or
thrombectomy performed in a timely manner [6].
Blood clots normally undergo contraction or mechanical
compression occurring under the action of the contractile
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